参考文献/References:
[1] Chu LW, Tam S, Kung AW,et al. Serum total and bioavailable testosterone levels, central obesity, and muscle strength changes with aging in healthy Chinese men[J].J Am Geriatr Soc, 2008,56(7):1286-1291. DOI: 10.1111/j.1532-5415.2008.01746.x.
[2] Araujo AB, Dixon JM, Suarez EA,et al. Clinical review: endogenous testosterone and mortality in men: a systematic review and meta-analysis[J].J Clin Endocrinol Metab, 2011,96(10):3007-3019. DOI: 10.1210/jc.2011-1137.
[3] Garcia-Cruz E, Piqueras M, Huguet J,et al. Hypertension, dyslipidemia and overweight are related to lower testosterone levels in a cohort of men undergoing prostate biopsy[J]. Int J Impot Res, 2012,24(3):110-113. DOI: 10.1038/ijir.2011.55.
[4] Firtser S, Juonala M, Magnussen CG,et al. Relation of total and free testosterone and sex hormone-binding globulin with cardiovascular risk factors in men aged 24-45 years. The Cardiovascular Risk in Young Finns Study[J].Atherosclerosis, 2012,222(1):257-262. DOI: 10.1016/j.atherosclerosis.2012.02.020.
[5] Stanworth RD, Kapoor D, Channer KS,et al. Dyslipidaemia is associated with testosterone, oestradiol and androgen receptor CAG repeat polymorphism in men with type 2 diabetes[J].Clin Endocrinol(Oxf), 2011,74(5):624-630. DOI: 10.1111/j.1365-2265.2011.03969.x.
[6] Mäkinen JI, Perheentupa A, Irjala K,et al. Endogenous testosterone and serum lipids in middle-aged men[J].Atherosclerosis, 2008,197(2):688-693.
[7] Zhang N, Zhang H, Zhang X,et al. The relationship between endogenous testosterone and lipid profile in middle-aged and elderly Chinese men[J].Eur J Endocrinol, 2014,170(4):487-494. DOI: 10.1530/EJE-13-0802.
[8] Bhasin S, Cunningham GR,Hayes FJ,et al.Testosterone therapy in men with androgen deficiency syndromes: an endocrine society clinical practice guideline[J]. J Clin Endocrinol Metab, 2010, 95(6): 2536-2559. DOI: 10.1210/jc.2009-2354.
[9] Haidar A, Yassin A, Saad F, et al. Effects of androgen deprivation on glycaemic control and on cardiovascular biochemical risk factors in men with advanced prostate cancer with diabetes[J].Aging Male, 2007,10(4):189-196. DOI:10.1080/13685530701653538.
[10] Zitzmann M, Nieschlag E. Androgen receptor gene CAG repeat length and body mass index modulate the safety of long-term intramuscular testosterone undecanoate therapy in hypogonadal men[J].J Clin Endocrinol Metab,2007,92(10):3844-3853. DOI:10.1210/jc.2007-0620.
[11] Corona G, Rastrelli G, Maggi M. Diagnosis and treatment of late-onset hypogonadism: systematic review and meta-analysis of TRT outcomes[J].Best Pract Res Clin Endocrinol Metab, 2013,27(4):557-579. DOI: 10.1016/j.beem.2013.05.002.
[12] Stokes KI, Benguzzi HA, Cameron JA. Physiological responses associated with sustained delivery of T, DHT, and AED inmale rats[J].Biomed Sci Instrum, 2000,36:209-214.
[13] Bruck B, Brehme U, Gugel N,et al. Gender-specific differences in the effects of testosterone and estrogen on the development of atherosclerosis in rabbits[J].Arterioscler Thromb Vasc Biol,1997,17(10):2192-2199.
[14] 王齐.降脂治疗对新西兰大白兔性激素和促甲状腺激素的影响[J].山东医药,2011,51(20):47-48.
[15] Arner P. Effects of testosterone on fat cell lipolysis. Species differences and possible role in polycystic ovarian syndrome[J].Biochimie, 2005,87(1):39-43. DOI:10.1016/j.biochi.2004.11.012.
[16] Zambon A, Bertocco S, Vitturi N,et al. Relevance of hepatic lipase to the metabolism of triacylglycerol-rich lipoproteins[J].Biochem Soc Trans, 2003,31(Pt 5):1070-1074.
[17] Barud W, Palusiński R, Betowski J,et al. Inverse relationship between total testosterone and anti-oxidized low density lipoprotein antibody levels in ageing males[J].Atherosclerosis, 2002,164(2):283-288.
[18] Ma R, Wu S, Lin Q. Homologous up-regulation of androgen receptor expression by androgen in vascular smooth muscle cells[J].Horm Res, 2005,63(1):6-14. DOI:10.1159/000082339.
[19] Langer C, Gansz B, Goepfert C,et al. Testosterone up-regulates scavenger receptor BI and stimulates cholesterol efflux from macrophages[J].Biochem Biophys Res Commun, 2002,296(5):1051-1057.
[20] Picard F, Kurtev M, Chung N,et al. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma[J].Nature,2004,429(6993):771-776. DOI:10.1038/nature02583.
[21] Asselbergs FW, Lovering RC, Drenos F. Progress in genetic association studies of plasma lipids[J].Curr Opin Lipidol, 2013,24(2):123-128. DOI: 10.1097/MOL.0b013e32835df2d6.
[22] Constantinou C, Mpatsoulis D, Natsos A,et al. The low density lipoprotein receptor modulates the effects of hypogonadism on diet-induced obesity and related metabolic perturbations[J].J Lipid Res, 2014,55(7):1434-1447. DOI: 10.1194/jlr.M050047.
[23] Alsiö J, Birgner C, Björkblom L,et al. Impact of nandrolone decanoate on gene expression in endocrine systems related to the adverse effects of anabolic androgenic steroids[J]. Basic Clin Pharmacol Toxicol, 2009,105(5):307-314. DOI: 10.1111/j.1742-7843.2009.00439.x.
[24] Karadeniz M, Erdogˇan M, Ayhan Z,et al. Effect of G2706A and G1051A polymorphisms of the ABCA1 gene on the lipid, oxidative stress and homocystein levels in Turkish patients with polycystic ovary syndrome[J].Lipids Health Dis, 2011,10:193. DOI: 10.1186/1476-511X-10-193.
[25] Delic' D, Ellinger-Ziegelbauer H, Vohr HW,et al. Testosterone response of hepatic gene expression in female mice having acquired testosterone-unresponsive immunity to plasmodium chabaudi malaria[J].Steroids, 2011,76(10-11):1204-1212. DOI: 10.1016/j.steroids.2011.05.013.
[26] Okamoto H, Yonemori F, Wakitani K,et al. A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits[J].Nature, 2000,406(6792):203-207. DOI:10.1038/35018119.
[27] 程京华,宫剑滨,张春妮,等.不同程度冠脉病变男性患者胆固醇酯转运蛋白水平及其临床意义[J].临床检验杂志,2009,27(1):47-49.DOI:10.13602/j.cnki.jcls.2009.01.024.
[28] de Haan W, de Vries-van der Weij J, van der Hoogt CC, et al. CETP as a target in HDL-raising therapy: lessons from APOE*3-Leiden CETP transgenic mice[J].Chin J Arterioscler,2009,17(7): 574-575.
[29] Dallas MJ. Accounting for interim safety monitoring of an adverse event upon termination of a clinical trial[J].J Biopharm Stat, 2008,18(4):631-638. DOI: 10.1080/10543400802071311.
相似文献/References:
[1]郑仁东,曹琳,刘克冕,等.超重或肥胖的男性2型糖尿病患者
性激素水平的研究[J].国际内分泌代谢杂志,2015,(02):84.[doi:10.3760/cma.j.issn.1673-4157.2015.02.004]
Zheng Rendong,Cao Lin,Liu Kemian,et al.Study on sex hormone levels in overweight or obese type 2 diabetic male patients[J].International Journal of Endocrinology and Metabolism,2015,(01):84.[doi:10.3760/cma.j.issn.1673-4157.2015.02.004]
[2]曹雯,郑仁东,曹琳,等.男性2型糖尿病患者血尿酸与性激素
相关性研究[J].国际内分泌代谢杂志,2016,36(01):28.[doi:10.3760/cma.j.issn.1673-4157.2016.01.007]
Cao Wen,Zheng Rendong,Cao Lin,et al.Correlation between blood uric acid and sex hormones in male patients with type 2 diabetes[J].International Journal of Endocrinology and Metabolism,2016,36(01):28.[doi:10.3760/cma.j.issn.1673-4157.2016.01.007]
[3]郑仁东,刘超.糖尿病合并男性性腺功能减退症的识别与处理[J].国际内分泌代谢杂志,2016,36(06):394.[doi:10.3760/cma.j.issn.1673-4157.2016.06.09]
Zheng Rendong,Liu Chao..Recognition and treatment of diabetes with male hypogonadism[J].International Journal of Endocrinology and Metabolism,2016,36(01):394.[doi:10.3760/cma.j.issn.1673-4157.2016.06.09]
[4]李进 狄红杰 刘超.慢性肾脏疾病和睾酮的相关性[J].国际内分泌代谢杂志,2018,38(03):209.[doi:10.3760/cma.j.issn.1673-4157.2018.03.016]
Li Jin*,Di Hongjie,Liu Chao.*.Correlation between chronic kidney disease and testosterone[J].International Journal of Endocrinology and Metabolism,2018,38(01):209.[doi:10.3760/cma.j.issn.1673-4157.2018.03.016]